HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $201,000 | -1.0% | 5,000 | 0.0% | 0.04% | -11.9% |
Q3 2021 | $203,000 | -10.6% | 5,000 | 0.0% | 0.04% | -8.7% |
Q2 2021 | $227,000 | -45.6% | 5,000 | -50.0% | 0.05% | -51.1% |
Q1 2021 | $417,000 | -34.9% | 10,000 | -33.3% | 0.09% | -37.3% |
Q4 2020 | $641,000 | +43.4% | 15,000 | -11.8% | 0.15% | +29.3% |
Q3 2020 | $447,000 | -2.0% | 17,000 | 0.0% | 0.12% | -13.4% |
Q2 2020 | $456,000 | +15.2% | 17,000 | -22.7% | 0.13% | -21.6% |
Q1 2020 | $396,000 | – | 22,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |